Novartis Ag (NVS) Return on Assets [ROA] (2009 - 2026)
Novartis Ag (NVS) reported Return on Assets [ROA] of 28.37% for Q2 2026, down 12.29 percentage points from 40.66% a year earlier and down 2.04 percentage points from the prior quarter.
Powered by 
Analysis
Novartis Ag (NVS) Return on Assets [ROA] (2009 - 2026) Analysis & Trends
For FY2025, Novartis Ag posted Return on Assets [ROA] of 13.10%, up 1.29 percentage points from FY2024.
- Return on Assets [ROA] has a five-year change of +6.54 percentage points (FY2020 to FY2025).
- By year, Return on Assets [ROA] came in at 11.81% in FY2024 (-1.86 pp), 13.67% in FY2023 (+8.08 pp), 5.58% in FY2022 (-12.92 pp) and 18.51% in FY2021 (+11.95 pp).
- The Q2 2026 figure ranks as the lowest quarterly Return on Assets [ROA] since Q4 2022.
- Year over year, Return on Assets [ROA] has now declined in each of the last six quarters, with an average year-over-year change of -5.06 percentage points over the last eight quarters.
- The high point for year-over-year Return on Assets [ROA] in five years was Q4 2023 (a gain of 17.75 percentage points); the low point was Q3 2025 (a drop of 13.58 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at 30.41% (Q1 2026), 32.61% (Q4 2025) and 31.35% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 10.47% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 28.37% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 2.14% |
| 10 | Vertex Pharmaceuticals | 127.87 Bn | 99.88 Bn | 2.84 Bn | 16.34% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 28.37% |
| Mar 31, 2026 | 30.41% |
| Dec 31, 2025 | 32.61% |
| Sep 30, 2025 | 31.35% |
| Jun 30, 2025 | 40.66% |
| Mar 31, 2025 | 40.33% |
| Dec 31, 2024 | 46.06% |
| Sep 30, 2024 | 44.93% |
| Jun 30, 2024 | 46.26% |
| Mar 31, 2024 | 44.72% |
| Dec 31, 2023 | 40.03% |
| Sep 30, 2023 | 32.21% |
| Jun 30, 2023 | 31.11% |
| Mar 31, 2023 | 29.69% |
| Dec 31, 2022 | 22.28% |
| Sep 30, 2022 | 27.47% |
| Jun 30, 2022 | 21.05% |
| Mar 31, 2022 | 21.25% |
| Dec 31, 2021 | 21.37% |
| Sep 30, 2021 | 9.78% |
API Access
Novartis Ag Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=NVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "NVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=NVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();